Jay Lin
Impact in
- Hepatology top 5%
- Hepatitis Viruses Studies and Epidemiology
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Hepatitis Viruses Studies and Epidemiology 4
-
- COVID-19 Clinical Research Studies 2
- HIV/AIDS drug development and treatment 2
- Co-authors
- Frederik Widén (4 shared papers)Manuela Di Fusco (3 shared papers)Jennifer L. Nguyen (3 shared papers)Heléne Norder (3 shared papers)Deepa Malhotra (2 shared papers)Birol Emir (1 shared paper)Melissa Lingohr-Smith (5 shared papers)Michael Benigno (1 shared paper)
- Journals
- Journal of Medical Economics (2 papers)Blood (1 paper)Journal of Medicinal Chemistry (1 paper)Journal of the American College of Cardiology (1 paper)Expert Review of Vaccines (1 paper)
- Partner nations
- United StatesSwedenFrance
In The Last Decade
Jay Lin
14 papers receiving 488 citations
Peers
Comparison fields: 5 of 56
- Hepatology 135
- Internal Medicine 28
- Infectious Diseases 165
- Economics and Econometrics 70
- Modeling and Simulation 11
Countries citing papers authored by Jay Lin
This map shows the geographic impact of Jay Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Lin more than expected).
Fields of papers citing papers by Jay Lin
This network shows the impact of papers produced by Jay Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Lin. The network helps show where Jay Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 143 | |
| 2 | 2022 | 63 | |
| 3 | 2013 | 51 | |
| 4 | 2010 | 49 | |
| 5 | 2016 | 37 | |
| 6 | 2014 | 35 | |
| 7 | 2015 | 34 | |
| 8 | Appropriate thromboprophylaxis in hospitalized cancer patients. | 2008 | 29 |
| 9 | 2010 | 20 | |
| 10 | 2016 | 18 | |
| 11 | 2022 | 17 | |
| 12 | Improving quality of care in oncology through healthcare payment reform. | 2018 | 10 |
| 13 | Initiating Injectable Therapy in US Managed Care Patients With Diabetes | 2014 | 1 |
| 14 | 2015 | 1 | |
| 15 | 2015 | 1 |
About Jay Lin
Jay Lin is a scholar working on Hepatology, Infectious Diseases, Internal Medicine, Organic Chemistry and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 509 indexed citations. Recurring topics across this work include Hepatitis Viruses Studies and Epidemiology (4 papers), Venous Thromboembolism Diagnosis and Management (2 papers), COVID-19 Clinical Research Studies (2 papers), HIV/AIDS drug development and treatment (2 papers), Pulmonary Hypertension Research and Treatments (1 paper), Organophosphorus compounds synthesis (1 paper), Atrial Fibrillation Management and Outcomes (1 paper) and Healthcare Policy and Management (1 paper). The work is most often cited by research in Hepatology (135 citations), Internal Medicine (28 citations), Infectious Diseases (165 citations), Economics and Econometrics (70 citations) and Modeling and Simulation (11 citations). Jay Lin has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Frederik Widén, Manuela Di Fusco, Jennifer L. Nguyen, Heléne Norder, Deepa Malhotra, Birol Emir, Melissa Lingohr-Smith, Michael Benigno, Jennifer Hammond and Anita Sung. Their work appears in journals such as Journal of Medical Economics, Blood, Journal of Medicinal Chemistry, Journal of the American College of Cardiology and Expert Review of Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.